US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Nutriband Inc. - Common Stock (NQ:NTRB)

6.680 -0.790 (-10.58%)
Delayed Quote Updated: 4:00 PM EDT, Oct 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Nutriband Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Marks Five-Year Anniversary of Nasdaq Listing
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Featured in Documentary Examining U.S. Opioid Crisis
Via Investor Brand Network
News headline image
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
Sheridan joins independent journalist Nick Shirley to discuss how Nutriband's AVERSA™ abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the... 
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Appoints Former Navy SEAL Robert J. O’Neill to Advisory Board
Via Investor Brand Network
News headline image
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
From Nutriband Inc.
Via GlobeNewswire
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Confirms Sept. 30 Expiration of Outstanding Warrants
Via Investor Brand Network
News headline image
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO to Attend Inaugural Nasdaq LaB Biotech Summit
Via Investor Brand Network
News headline image
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
From Nutriband Inc.
Via GlobeNewswire
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Advances Trademark Protection for Abuse-Deterrent Fentanyl Patch
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
MissionIRNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO to Present at 2026 Georgia Life Sciences Summit
Via Investor Brand Network
News headline image
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) CEO Highlights AVERSA Technology on Jack Neel Podcast
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Selects Global Brand Name Candidate for AVERSA(TM) Fentanyl Patch
Via Investor Brand Network
News headline image
Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Secures Costa Rica Approval for Kinesiology Tape Line
Via Investor Brand Network
News headline image
Nutriband AI Kinesiology Tapes approved for Distribution and Sale in Costa Rica
The Company recently announced an exclusive distribution agreement with Innomedica CCB S.A. for its Kinesiology Line, AVERSA products and Mosquito repellent patches 
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Signs Exclusive Costa Rica Distribution Deal for AVERSA Fentanyl and Sports Tape Products
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica
From Nutriband Inc.
Via GlobeNewswire
BioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) Highlights Board Appointments and AVERSA Fentanyl Milestones From Annual Meeting
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points
From Nutriband Inc.
Via GlobeNewswire
NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) CEO Issues Shareholder Letter Highlighting 2025 Milestones and 2026 Outlook
Via Investor Brand Network
Topics Intellectual Property
News headline image
Nutriband CEO Publishes Letter to Shareholders
From Nutriband Inc.
Via GlobeNewswire
News headline image
What’s Driving Nutriband Shares Higher Today? ↗
Nutriband has agreed to sell 90% of its stake in its subsidiary Pocono Pharmaceuticals for $5 million. 
Via Stocktwits
Topics Artificial Intelligence Government
InvestorNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Sells 90% Stake in Pocono Pharmaceutical for $5 Million
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >